Related Experiment Video

Updated: Dec 16, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.0K

Targeting NUPR1 for Cancer Treatment: A Risky Endeavor

Salma M A Mansour1, Sahar A Ali2, Shaira Nofal3

  • 1Egyptian Patent Office, Academy of Scientific Research and Technology (ASRT), 101 Kaser Al-Ainy Street, Cairo, Egypt.

Current Cancer Drug Targets
|July 4, 2020
PubMed

Insights

Nuclear protein transcription regulator 1 (NUPR1) plays diverse roles in cancer, regulating complex pathways. Targeting NUPR1 for cancer therapy is challenging due to incompletely understood mechanisms and varied effects across cancer types.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Nuclear protein 1 (NUPR1) is a transcription factor implicated in various cellular processes.
  • NUPR1 has garnered significant attention for its multifaceted roles in cancer development and progression.
  • Understanding NUPR1's molecular targets and mechanisms is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To elucidate the role of NUPR1 in different types of cancer.
  • To highlight the complex regulatory network governed by NUPR1.
  • To assess the potential and challenges of targeting NUPR1 in cancer treatment.

Main Methods:

  • Literature review and analysis of existing studies on NUPR1.
  • Examination of NUPR1's involvement in various cancer signaling pathways.
  • Evaluation of the impact of NUPR1 silencing on cancer cells.

Main Results:

  • NUPR1 regulates a complex network of pathways with variable effects upon silencing.
  • NUPR1's role is well-documented in some cancers but remains poorly understood in others.
  • The precise function of NUPR1 varies significantly across different cancer types.

Conclusions:

  • Targeting NUPR1 for cancer treatment presents significant challenges due to its complex and varied roles.
  • Further research is needed to fully understand NUPR1's mechanisms in all cancer types before therapeutic strategies can be reliably developed.
  • The therapeutic targeting of NUPR1 remains a high-risk, complex endeavor in oncology.
Keywords:
Com-1NUPR1cancer inhibitioncancer progressionchemoresistancep8stress protein

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.0K
Production of Nurr-1 Specific Polyclonal Antibodies Free of Cross-reactivity Against Its Close Homologs, Nor1 and Nur7712:30

Production of Nurr-1 Specific Polyclonal Antibodies Free of Cross-reactivity Against Its Close Homologs, Nor1 and Nur77

Published on: August 17, 2015

7.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
438
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K